Exact Sciences [EXAS] vs Agilent Technologies [A] Detailed Stock Comparison

Exact Sciences Corp

NASDAQ
Loading...

Agilent Technologies Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Exact Sciences Corp wins in 3 metrics, Agilent Technologies Inc. wins in 16 metrics, with 0 ties. Agilent Technologies Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Exact Sciences Corp Agilent Technologies Inc. Better
P/E Ratio (TTM) -95.37 25.67 Agilent Technologies Inc.
Price-to-Book Ratio 8.34 4.76 Agilent Technologies Inc.
Debt-to-Equity Ratio 105.57 51.39 Agilent Technologies Inc.
PEG Ratio 55.22 -7.19 Exact Sciences Corp
EV/EBITDA 302.23 17.32 Agilent Technologies Inc.
Profit Margin (TTM) -6.40% 18.26% Agilent Technologies Inc.
Operating Margin (TTM) -9.28% 22.86% Agilent Technologies Inc.
EBITDA Margin (TTM) N/A 22.86% N/A
Return on Equity -8.66% 19.95% Agilent Technologies Inc.
Return on Assets (TTM) -1.59% 8.53% Agilent Technologies Inc.
Free Cash Flow (TTM) $356.78M $1.15B Agilent Technologies Inc.
Dividend Yield N/A 0.68% N/A
1-Year Return 140.29% 10.90% Exact Sciences Corp
Price-to-Sales Ratio (TTM) 6.17 4.65 Agilent Technologies Inc.
Enterprise Value $21.60B $34.13B Agilent Technologies Inc.
EV/Revenue Ratio 6.65 4.83 Agilent Technologies Inc.
Gross Profit Margin (TTM) 70.11% 52.61% Exact Sciences Corp
Revenue per Share (TTM) $17 $25 Agilent Technologies Inc.
Earnings per Share (Diluted) $-1.10 $4.53 Agilent Technologies Inc.
Beta (Stock Volatility) 1.44 1.30 Agilent Technologies Inc.
Short % of Float 3.92% 1.83% Agilent Technologies Inc.

Exact Sciences Corp vs Agilent Technologies Inc. Stock Performance Analysis

Loading Price Chart...

EXAS
A

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Exact Sciences Corp0.00%1.02%1.47%3.27%100.17%3.12%
Agilent Technologies Inc.-3.41%-2.11%3.78%7.87%-3.22%-4.70%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Exact Sciences Corp140.29%54.71%-20.87%1,407.33%1,337.12%3,317.26%
Agilent Technologies Inc.10.90%7.19%-10.46%186.24%282.67%444.17%

Performance & Financial Health Analysis: Exact Sciences Corp vs Agilent Technologies Inc.

MetricEXASA
Market Information
Market Cap i$20.03B$32.65B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i3,743,5831,922,585
90 Day Avg. Volume i2,715,0141,892,452
Last Close$104.91$131.46
52 Week Range$38.81 - $104.98$108.35 - $160.27
% from 52W High-0.07%-17.98%
All-Time High$159.54 (Jan 25, 2021)$179.57 (Aug 30, 2021)
% from All-Time High-34.24%-26.79%
Growth Metrics
Quarterly Revenue Growth0.23%0.07%
Quarterly Earnings Growth0.23%-0.04%
Financial Health
Profit Margin (TTM) i-0.06%0.18%
Operating Margin (TTM) i-0.09%0.23%
Return on Equity (TTM) i-0.09%0.20%
Debt to Equity (MRQ) i105.5751.39
Cash & Liquidity
Book Value per Share (MRQ)$12.58$24.44
Cash per Share (MRQ)$5.05$6.22
Operating Cash Flow (TTM) i$491.44M$1.40B
Levered Free Cash Flow (TTM) i$281.87M$855.88M
Dividends
Last 12-Month Dividend Yield iN/A0.68%
Last 12-Month Dividend iN/A$1.01

Valuation & Enterprise Metrics Analysis: Exact Sciences Corp vs Agilent Technologies Inc.

MetricEXAS (Apr 07, 2026)A (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i-95.3725.67
Forward P/E i55.2217.67
PEG Ratio i55.22-7.19
Price to Sales (TTM) i6.174.65
Price to Book (MRQ) i8.344.76
Market Capitalization
Market Capitalization i$20.03B$32.65B
Enterprise Value i$21.60B$34.13B
Enterprise Value Metrics
Enterprise to Revenue i6.654.83
Enterprise to EBITDA i302.2317.32
Risk & Other Metrics
Beta i1.441.30
Book Value per Share (MRQ) i$12.58$24.44

Financial Statements Comparison: Exact Sciences Corp vs Agilent Technologies Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricEXAS (2025)A (2025)
Revenue/Sales i3.25B6.95B
Cost of Goods Sold i984.24M3.31B
COGS % of Revenue i30.3%47.6%
Gross Profit i2.26B3.64B
Gross Margin i69.7%52.4%
Research & Development i523.00M455.00M
Operating Income (EBIT) i-199.10M1.48B
Operating Margin i-6.1%21.3%
EBITDA i17.87M1.84B
EBITDA Margin i0.6%26.4%
Pre-Tax Income i-203.89M1.44B
Pre-Tax Income % of Revenue i-6.3%20.7%
Income Tax i4.06M132.00M
Income Tax % of Revenue i0.1%1.9%
Net Income (Profit) i-207.95M1.30B
Profit Margin i-6.4%18.8%

Balance Sheet & Liquidity Metrics

MetricEXAS (2025)A (2025)
Cash & Equivalents i956.00M1.79B
Total Current Assets i1.56B4.59B
Total Current Assets % of Revenue i47.9%66.1%
Total Current Liabilities i641.15M2.35B
Total Current Liabilities % of Revenue i19.7%33.8%
Long-Term Debt i2.49B3.05B
Long-Term Debt % of Revenue i76.7%43.9%
Total Shareholders Equity i2.40B6.74B
Retained Earnings i-4.71B1.39B
Retained Earnings % of Revenue i-144.9%20.0%
Property, Plant & Equipment i122.33M0

Cash Flow Statement Comparison

MetricEXAS (2025)A (2025)
Operating Cash Flow i273.28M1.51B
Operating Cash Flow % of Revenue i8.4%21.7%
Capital Expenditures i-134.66M-407.00M
Free Cash Flow i356.78M1.15B
FCF Margin i11.0%16.6%
Debt Repayment i-249.17M-3.00M
Common Stock Repurchase iN/A-425.00M

Short Interest & Institutional Ownership Analysis

MetricEXASA
Shares Short i7.40M4.55M
Short Ratio i3.231.93
Short % of Float i3.92%1.83%
Shares Outstanding i190.80M282.70M
Float Shares i188.45M281.64M
% Held by Insiders i1.23%0.19%
% Held by Institutions i86.48%93.87%
% Held by Public i12.29%5.94%

Dividend Analysis & Yield Comparison: Exact Sciences Corp vs Agilent Technologies Inc.

MetricEXASA
Last 12-Month Dividend iN/A$1.01
Last 12-Month Dividend Yield iN/A0.68%
3-Year Avg Annual Dividend iN/A$0.97
3-Year Avg Dividend Yield iN/A0.18%
3-Year Total Dividends iN/A$2.91
Ex-Dividend DateN/AJan 06, 2026